摘要
目的:检测铜绿假单胞菌对β-内酰胺酶类抗生素的耐药性,为临床合理应用抗生素提供参考依据。方法:采用K-B扩散法测定亚胺培南等7种抗菌药物对46株铜绿假单胞菌的体外抗菌活性,采用冻融法粗提铜绿假单胞菌酶液,用改良三维试验分析β-内酰胺酶类型。结果:46株铜绿假单胞菌均对3种以上抗生素耐药,表现为多重耐药。三维试验阳性率52.2%(24/46),其中单一产AmpC酶菌株15株,单一产ESBLs菌株6株,同时产AmpC酶及ESBLs菌株2株,1株产其它β-内酰胺酶。结论:产生β-内酰胺酶是铜绿假单胞菌对β-内酰胺酶类抗生素耐药的主要机制之一,其中β-内酰胺酶以产AmpC酶为主,是造成临床上铜绿假单胞菌对头孢菌素第3、4代耐药的主要原因。
Objective: To investigate the mechanism of drug-resistance associated with β-lactamase in Pseudomonas aeruginosa and provide evidence of using antibiotic rationally.Methods: 46 strains of Pseudomonas aeruginosa were isolated from patients.K-B disk diffusion method was used in susceptibility testing.A modified three-dimensional test was used to detected the type of the β-lactamase.Results: In 46 strains of Pseudomonas aeruginosa,the total positive rate of β-lactamase was 52.2%(24/46),the positive rate of ESBLs and AmpCβ-lactamase were 13.0%(6/46) and 32.6%(15/46) respectively.Both AmpC and ESBLs positive is 4.3%(2/46),other β-lactamase positive is 2.2%(1/46).Conclusion:The production of β-lactamase is the major mechanism of the drug-resistance associated withβlactamase antibiotics in Pseudomonas aeruginosa.The production of AmpC enzymes was the main cause for the resistance to the third and fourth generation cephalosporin in Pseudomonas aeruginosa.
出处
《中国医药导刊》
2012年第4期659-660,662,共3页
Chinese Journal of Medicinal Guide